Chinese hamster-human somatic cell hybrids were analyzed for the expression of human galactose-l-phosphate uridyltransferase (GALT; UDPglucose:a-D-galactose-1-phosphate uridyltransferase, EC 2.7.7.12) by electrophoresis and for the presence of human chromosomes cytogenetically with the aid of Q-banding. Three of the 10 randomly chosen independently derived primary hybrid lines showed the presence of human GALT. Human chromosome 9 was consistently present in the hybrid lines expressing human GALT and consistently absent in the' lines not expressing it. Biochemical analysis alone of 11 independently derived hybrid lines showed human GALT to be syntenic with known chromosome 9 markers (soluble aconitase, adenylate kinase 1, and adenylate kinase 3). Previous studies on chromosome assignment of this locus, utilizing somatic cell hybrids, have yielded inconsistent results; one group assigned GALT to chromosome 2, and another assigned it to chromosome 3. However, we believe that, based on our results and other published evidence, the correct assignment of the human GALT locus is to chromosome 9.
Genetic analysis of rodent-human somatic cell hybrids has permitted rapid expansion of our knowledge of the human gene map (1) . These interspecific hybrid cells lose human chromosomes preferentially and at random. It is thus possible to assign a human gene marker to a specific human chromosome by correlating the presence of that marker with the presence of the human chromosome in a series of independently derived hybrid lines. The enzyme galactose-1-phosphate uridyltransferase (GALT, UDPglucose:a-D-galactose-l-phosphate uridyltransferase, EC 2.7.7.12) catalyzes the conversion of galactose-1-phosphate to glucose-1-phosphate in the Leloir pathway. Genetic variants of this enzyme have been described, and a deficiency of it occurs in an autosomal recessive inborn error of metabolism in man (2) . Attempts to assign the gene locus for human GALT, using somatic cell hybrid techniques, have yielded inconsistent results in the past. Sun et al. (3) assigned the locus to chromosome 2 based on their studies with Chinese hamster-human-somatic cell hybrids, and Tedesco et al. (4) assigned the GALT locus to chromosome 3 based on their data from mouse-human hybrid cells. However, results of synteny testing by Westerveld et al. (5) are compatible with the assignment of this locus to chromosome 9 . We present here direct evidence for the assignment of the human gene locus for GALT to chromosome 9 from a series of independently derived Chinese hamster-human somatic cell hybrids.
MATERIALS AND METHODS
Production of Somatic Cell Hybrids. A hypoxanthine phosphoribosyltransferase-deficient, tetraploid Chinese hamster line was fused with human lymphocytes obtained from a balanced translocation carrier with a karyotype of 46,XX, t(3;4)-(q27;q25). Cell fusion was done in suspension with the aid of inactivated Sendai virus, according to the method of Giles and Ruddle (6) . The initial fusion mixture was diluted and plated in several small culture vessels, and hybrid cells were selected in medium containing thymidine, hypoxanthine, aminopterin, and glycine. Only one colony was picked from each culture vessel to ensure the independent origin of the hybrid lines. After their isolation in this medium, hybrid lines were subsequently grown in nonselective growth medium.
Biochemical Analysis. Synchronized biochemical and cytogenetic analyses were done for the presence of human GALT and for human chromosome content on each of 10 3/4 refers to the derived chromosome 3 from the balanced translocation (3pter -3q27::4q25 -4qter). Descriptions of rearranged human chromosomes are according to the Paris Conference (14) . § 4/3 refers to the derived chromosome 4 from the balanced translocation (4pter -4q25::3q27 -3qter).
I This marker chromosome is derived from an interspecific translocation between Chinese hamster chromosome 1 and human chromosome 3/4. This marker chromosome has an extra band at the distal end of the long arm of human chromosome 1, most likely a duplication of the terminal band. ** This is a deletion of 3/4 chromosome at p21 band of chromosome 3. phoglucomutase (500 units/ml), 20 jl of glucose-6-phosphate dehydrogenase (345 units/ml), 1 ml of 0.2 M MgG12, 1 ml of 3-(4,5-dimethyl thiazolyl-2) 2,5-diphenyl tetrazolium bromide (2 mg/ml), 1 ml of phenazine methosulfate (1 mg/ml), and 15 ml of 2% agarose solution cooled to about 500. Optimal staining occurred in about 1'/2 hr at 37°. On this gel, superoxide dismutase can also be detected (7); phosphoglycerate kinase (8), glucose-6-phosphate dehydrogenase (9) , ACONS (10), AK' (11), and AK3 (12) were evaluated by described techniques.
Cytogenetic Analysis. Standard air-dried preparations were made from hybrid lines and stained with quinacrine mustard (13 9. The AK3 locus has also been assigned to human chromosome 9 provisionally (15) and our results from synteny testing support this assignment. Other studies in our laboratory on five hybrid lines with a human X/9 translocation and three hybrid lines with a human 17/9 translocation support the assignment of the GALT locus to chromosome 9 and probably to its short arm.
The data presented here are in conflict with previous assignments of the locus for human GALT It is more difficult to explain the discrepancy between our results and those of Tedesco et al. (4) with mouse-human hybrids. These authors analyzed 33 hybrid clones cytogenetically but did not state how many were independently derived primary hybrid clones. The distribution of the human chromosomes in the 17 hybrid lines presented raises the possibility that they were not all independently derived; the clone panel analyzed by Tedesco et al. does not cover all the human autosomes, and certain human chromosomes are present in the majority of the lines. Theoretically, conflicting assignments for an enzyme locus could result if the enzyme is under the control of more than one gene locus, but to date there appears to be no evidence for this possibility in the case of GALT.
The assignment of the GALT locus to chromosome 3 by using mouse-human hybrid cells is apparently supported by the observation that the erythrocytes of a patient trisomic for the q21 -qter region and monosomic for the p25 --pter region of chromosome 3 had an increased level of GALT (19) . Gene dosage effect from a single individual provides only suggestive evidence, but not proof, for gene localization. The increased level of enzyme need not necessarily be due to the location of the structural gene locus in the region of the chromosome for which the individual was trisomic; an alternate possibility is location of regulatory gene(s) in that region. Also, as noted by these authors, a GALT variant such as the Los Angeles (LA) could lead to increased activity, and this possibility was not ruled out by evaluating the enzyme with electrophoresis.
Our results indicating the assignment of the human GALT locus to chromosome 9 are supported by indirect evidence already published. Westerveld et al. (5) observed that GALT was syntenic with aconitase in 39 primary Chinese-hamster-human hybrid clones without exception and in a combined total of 60 primary and secondary clones with 2 exceptions. Although the authors did not state whether the aconitase evaluated was cytoplasmic or mitochondrial, their photograph of the gel shows it to be cytoplasmic (anodal band). The cytoplasmic form af aconitase has since been assigned to chromosome 9 and confirmed, as indicated above. Furthermore, Weber et al. (20) observed an elevated level of GALT (34.5 units/ml versus 18-28 for the normal) in the erythrocytes of a patient trisomic for the short arm of chromosome 9, resulting from the segregation of a translocation. This may suggest localization of the GALT locus to the short arm of chromosome 9. The possibility that an LA variant was causing the increased activity could not be ruled out in the study by Weber et al. As demonstrated by the studies referred to above, one has to be cautious in using gene dosage effect from a single patient as evidence for regional localization of gene loci. It appears that the patient who is partially trisomic (and partially monosomic) for chromosome 3 and the patient who is trisomic for the short arm of chromosome 9 have an elevated level of GALT.
We believe that, based on our analysis of the Chinese hamster-human hybrid lines presented here and the data published by Westerveld et al. (5) , the correct assignment of the human GALT gene is to chromosome 9. This work was supported in part by Grants HD-04612 and HD-05615 from the National Institute of Child Health and Human Development.
